2-[4-(4-Chlorophenyl)-2-methyl-3-oxo-1,2,4-oxadiazolidin-5-yl]-N-(2-methyl-4-nitrophenyl)acetamide

Catalog No. :
ACWBPY059
CAS No. :
478077-80-4
Molecular Formula :
C18H17ClN4O5
Molecular Weight :
404.81

IUPAC Name:2-(4-(4-chlorophenyl)-2-methyl-3-oxo-1,2,4-oxadiazolidin-5-yl)-N-(2-methyl-4-nitrophenyl)acetamide

2-[4-(4-Chlorophenyl)-2-methyl-3-oxo-1,2,4-oxadiazolidin-5-yl]-N-(2-methyl-4-nitrophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[4-(4-Chlorophenyl)-2-methyl-3-oxo-1,2,4-oxadiazolidin-5-yl]-N-(2-methyl-4-nitrophenyl)acetamide
IUPAC Name2-(4-(4-chlorophenyl)-2-methyl-3-oxo-1,2,4-oxadiazolidin-5-yl)-N-(2-methyl-4-nitrophenyl)acetamide
Molecular FormulaC18H17ClN4O5
Molecular Weight404.81
SMILESO=C(NC1=CC=C([N+]([O-])=O)C=C1C)CC(ON2C)N(C3=CC=C(Cl)C=C3)C2=O
InChI KeyOGRJEWQGRHQDMH-UHFFFAOYSA-N
Synonym2-[4-(4-CHLOROPHENYL)-2-METHYL-3-OXO-1,2,4-OXADIAZOLAN-5-YL]-N-(2-METHYL-4-NITROPHENYL)ACETAMIDE;2-[4-(4-chlorophenyl)-2-methyl-3-oxo-1,2,4-oxadiazolidin-5-yl]-N-(2-methyl-4-nitrophenyl)acetamide;1,2,4-Oxadiazolidine-5-acetamide, 4-(4-chlorophenyl)-2-methyl-N-(2-methyl-4-nitrophenyl)-3-oxo-
CAS No.478077-80-4

Synthetic Route by SureRoute

1. ACWBPY059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWBPY059 route product structure diagram
    ACWBPY059478077-80-4
Inquiry

2. ACWBPY059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWBPY059 route product structure diagram
    ACWBPY059478077-80-4
Inquiry

Comments (0)